CGB-S-100

N/A

Report date: 2022/12/15 19:41:39
NME

Base Information

Drug NameCGB-S-100
Drug Alias NameCGB-S-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBlind Loop SyndromeBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCAGE Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesCAGE Bio Inc
Inactive CompaniesN/A
Active IndicationsBlind Loop Syndrome
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A